华商基金刘力：2026年关注国产AI、创新药、商业航天三大领域

Core Insights - The article emphasizes three key investment directions for 2026: the domestic AI ecosystem, innovative pharmaceuticals, and the commercial aerospace sector, which are expected to lead market trends [1][6]. Group 1: Domestic AI Ecosystem - The domestic AI ecosystem is anticipated to experience a comprehensive explosion this year, driven by rapid advancements in large model technology and increased application penetration [4][9]. - The AI industry in China is expected to replicate the growth trajectory seen overseas, positively impacting related sectors [9]. - The AI industry chain includes downstream areas focused on large models and cloud computing, while upstream sectors encompass AI chips, storage, semiconductor manufacturing, and related materials [9]. Group 2: Innovative Pharmaceuticals - The innovative pharmaceutical sector has shown signs of explosive growth over the past 2-3 years, despite experiencing a pullback due to valuation pressures in the latter half of last year [5][9]. - Companies with overseas capabilities and strong pipeline execution are seen as having favorable positioning for investment during current market adjustments [5]. Group 3: Commercial Aerospace Sector - The commercial aerospace sector, particularly in areas like rocket recovery and low-orbit satellites, is expected to accelerate commercialization over the next 5 to 10 years, presenting clear growth paths [5][9]. - This sector is characterized by both thematic and growth attributes, making it a focal point for investment [5].